EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Pathomics-Based Prognostic Model for Disease-Free Survival in Resected Gastric Cancer

Liyun Zheng, Zhiying Jin, Fazong Wu, Shiman Zhu, Yeyu Zhang, Li Chen, Wanbin Chen, Chaoming Huang, Lingyi Zhu, Shiji Fang, Zijian Zhu, Qi Huang und 4 weitere

Cancers · 19.03.2026 · 18 (6) · 993

DOI: 10.3390/cancers18060993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 19.03.2026. Verfasst von Liyun Zheng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Imaging and Interventional Medicine, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Project of the Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aims to develop and validate a prognostic risk model by integrating pathomics features with clinical variables to predict disease-free survival (DFS) in patients with gastric cancer (GC).

Methods

Patients with GC who were pathologically diagnosed and subsequently treated with curative gastrectomy and D2 lymphadenectomy at the Fifth Affiliated Hospital of Wenzhou Medical University between January 2017 and April 2023 were retrospectively enrolled and assigned to a training cohort (n = 275) and an independent validation cohort (n = 118). Pathomics features were extracted from pathological images, and LASSO-Cox regression was used to identify pathomics features significantly associated with DFS. The selected pathomics features were integrated with clinical factors to create a prognostic model. Predictive accuracy was evaluated using time-dependent ROC analysis, and the model’s performance was compared with the clinic-only and pathomics-only models. A nomogram was constructed to provide individualized DFS predictions.

Results

A total of 16 pathomics features were selected, and the cut-off for the pathomics scores was set at 0.27. High-risk patients exhibited significantly worse DFS compared to low-risk patients in both the training cohort (HR = 4.57, 95% CI: 3.118–6.697, p < 0.0001) and the validation cohort (HR = 2.264, 95% CI: 1.255–4.083, p < 0.0001). The clinic–pathomics model demonstrated strong predictive performance in both cohorts, with AUCs for 1-, 3-, and 5-year survival of 0.832, 0.821, and 0.851 in the training cohort, and 0.671, 0.702, and 0.682 in the validation cohort. The nomogram, incorporating the pathomics score, T stage, differentiation degree, and ECOG performance status, showed high calibration accuracy, as confirmed by calibration plots, and outperformed both the clinic-only and pathomics-only models in decision curve analysis.

Conclusions

A clinic–pathomics model integrating pathomics features with clinical data provides a reliable tool for DFS prediction in patients with GC, which facilitates individualized DFS predictions and personalized treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

clinical variablesdisease-free survivalgastric cancernomogrampathomicsprognostic model

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Imaging and Interventional Medicine, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Cancer Center, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Department of Radiology, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Clinical College of The Affiliated Central Hospital, School of Medicine, Lishui University, Lishui 323000, China.

Förderung

  • Key Project of the Natural Science Foundation of Zhejiang Province

Zitieren

APA

Zheng, L., Jin, Z., Wu, F., Zhu, S., Zhang, Y., Chen, L., Chen, W., Huang, C., Zhu, L., Fang, S., Zhu, Z., Huang, Q., Chen, M., Zhao, Z., Li, W., & Cheng, S. (2026). A Pathomics-Based Prognostic Model for Disease-Free Survival in Resected Gastric Cancer. Cancers, 18(6), 993. https://doi.org/10.3390/cancers18060993

Vancouver

Zheng L, Jin Z, Wu F, Zhu S, Zhang Y, Chen L, et al. A Pathomics-Based Prognostic Model for Disease-Free Survival in Resected Gastric Cancer. Cancers. 2026;18(6):993. doi:10.3390/cancers18060993

BibTeX
@article{Zheng2026,
  author = {Zheng, Liyun and Jin, Zhiying and Wu, Fazong and Zhu, Shiman and Zhang, Yeyu and Chen, Li and Chen, Wanbin and Huang, Chaoming and Zhu, Lingyi and Fang, Shiji and Zhu, Zijian and Huang, Qi and Chen, Minjiang and Zhao, Zhongwei and Li, Weiwen and Cheng, Shimiao},
  title = {A Pathomics-Based Prognostic Model for Disease-Free Survival in Resected Gastric Cancer},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {993},
  doi = {10.3390/cancers18060993}
}
Kostenlos starten →